General Information
Drug ID
DR01443
Drug Name
Norverapamil
Synonyms
Arverapamil; (R)-norverapamil; Agi-003; UNII-3J8P56R04P; (R)-(+)-Nor Verapamil Hydrochloride; 123932-43-4; 3J8P56R04P; Rezular; (+)-norverapamil; (R)-desmethylverapamil; (+)-desmethylverapamil; CHEBI:134082; ZINC13492624; AKOS030532539; Benzeneacetonitrile, alpha-(3-((2-(3,4-dimethoxyphenyl)ethyl)amino)propyl)-3,4-dimethoxy-alpha-(1-methylethyl)-, (alphaR)-; UNII-957Z3K3R56 component UPKQNCPKPOLASS-AREMUKBSSA-N
Drug Type
Small molecular drug
Indication Irritable bowel syndrome [ICD11: DD91.0] Phase 2 [1]
Formula
C26H36N2O4
Canonical SMILES
CC(C)C(CCCNCCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC
InChI
InChI=1S/C26H36N2O4/c1-19(2)26(18-27,21-9-11-23(30-4)25(17-21)32-6)13-7-14-28-15-12-20-8-10-22(29-3)24(16-20)31-5/h8-11,16-17,19,28H,7,12-15H2,1-6H3
InChIKey
UPKQNCPKPOLASS-UHFFFAOYSA-N
CAS Number
CAS 67018-85-3
Pharmaceutical Properties Molecular Weight 440.6 Topological Polar Surface Area 72.7
Heavy Atom Count 32 Rotatable Bond Count 13
Hydrogen Bond Donor Count 1 Hydrogen Bond Acceptor Count 6
XLogP
3.3
PubChem CID
104972
ChEBI ID
CHEBI:134080
TTD Drug ID
D0N1CH
DT(s) Transporting This Drug P-GP Transporter Info P-glycoprotein 1 Substrate [2]
References
1 Emerging drugs for irritable bowel syndrome. Expert Opin Emerg Drugs. 2006 May;11(2):293-313.
2 Characterization of the major metabolites of verapamil as substrates and inhibitors of P-glycoprotein. J Pharmacol Exp Ther. 2000 May;293(2):376-82.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.